Kelly S, Jahanshad N, Zalesky A, Kochunov P, Agartz I, Alloza C, et al. Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group. Mol Psychiatry. 2017;23:1261–9.
Kubicki M, McCarley R, Westin C-F, Park H-J, Maier S, Kikinis R, et al. A review of diffusion tensor imaging studies in schizophrenia. J Psychiatr Res. 2007;41:15–30.
Wheeler AL, Voineskos AN. A review of structural neuroimaging in schizophrenia: from connectivity to connectomics. Front Hum Neurosci. 2014;8:653.
Holleran L, Kelly S, Alloza C, Agartz I, Andreassen OA, Arango C, et al. The relationship between white matter microstructure and general cognitive ability in patients with schizophrenia and healthy participants in the ENIGMA Consortium. Am J Psychiatry. 2020;177:537–47.
Cetin-Karayumak S, Biase MAD, Chunga N, Reid B, Somes N, Lyall AE, et al. White matter abnormalities across the lifespan of schizophrenia: a harmonized multi-site diffusion MRI study. Mol Psychiatry. 2019;25:3208–19.
O’Donnell LJ, Pasternak O. Does diffusion MRI tell us anything about the white matter? An overview of methods and pitfalls. Schizophr Res. 2015;161:133–41.
Jones DK, Knösche TR, Turner R. White matter integrity, fiber count, and other fallacies: the do’s and don’ts of diffusion MRI. NeuroImage. 2013;73:239–54.
Pasternak O, Sochen N, Gur Y, Intrator N, Assaf Y. Free water elimination and mapping from diffusion MRI. Magn Reson Med. 2009;62:717–30.
Pasternak O, Westin C-F, Bouix S, Seidman LJ, Goldstein JM, Woo T-UW, et al. Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset. J Neurosci. 2012;32:17365–72.
Lyall AE, Pasternak O, Robinson DG, Newell D, Trampush JW, Gallego JA, et al. Greater extracellular free-water in first-episode psychosis predicts better neurocognitive functioning. Mol Psychiatry. 2018;23:701–7.
Lesh TA, Maddock RJ, Howell A, Wang H, Tanase C, Daniel Ragland J, et al. Extracellular free water and glutathione in first-episode psychosis-a multimodal investigation of an inflammatory model for psychosis. Mol Psychiatry. 2021;26:761–71.
Bergé D, Mané A, Lesh TA, Bioque M, Barcones F, Gonzalez-Pinto AM, et al. Elevated extracellular free-water in a multicentric first-episode psychosis sample, decrease during the first 2 years of illness. Schizophr Bull 2020;46:846–56.
Guo JY, Lesh TA, Niendam TA, Ragland JD, Tully LM, Carter CS. Brain free water alterations in first-episode psychosis: a longitudinal analysis of diagnosis, course of illness, and medication effects. Psychol Med. 2020;45:1–10.
Pasternak O, Westin CF, Dahlben B, Bouix S, Kubicki M. The extent of diffusion MRI markers of neuroinflammation and white matter deterioration in chronic schizophrenia. Schizophr Res. 2015;161:113–8.
Oestreich LKL, Lyall AE, Pasternak O, Kikinis Z, Newell DT, Savadjiev P, et al. Characterizing white matter changes in chronic schizophrenia: a free-water imaging multi-site study. Schizophr Res. 2017;189:153–61.
Gurholt TP, Haukvik UK, Lonning V, Jönsson EG, Pasternak O, Agartz I. Microstructural white matter and links with subcortical structures in chronic schizophrenia: a free-water imaging approach. Front Psychiatry. 2020;11:56.
Mandl RCW, Pasternak O, Cahn W, Kubicki M, Kahn RS, Shenton ME, et al. Comparing free water imaging and magnetization transfer measurements in schizophrenia. Schizophr Res. 2015;161:126–32.
Chang X, Mandl RCW, Pasternak O, Brouwer RM, Cahn W, Collin G, et al. Diffusion MRI derived free-water imaging measures in patients with schizophrenia and their non-psychotic siblings. Prog Neuro-Psychopharmacol Biol Psychiatry. 2021;109:110238.
Karayumak SC, Bouix S, Ning L, James A, Crow T, Shenton M, et al. Retrospective harmonization of multi-site diffusion MRI data acquired with different acquisition parameters. NeuroImage. 2019;184:180–200.
Seitz-Holland J, Cetin-Karayumak S, Wojcik JD, Lyall A, Levitt J, Shenton ME, et al. Elucidating the relationship between white matter structure, demographic, and clinical variables in schizophrenia—a multicenter harmonized diffusion tensor imaging study. Mol Psychiatry. 2021;26:5357–70.
Elad D, Cetin‐Karayumak S, Zhang F, Cho KIK, Lyall AE, Seitz‐Holland J, et al. Improving the predictive potential of diffusion MRI in schizophrenia using normative models—towards subject‐level classification. Hum Brain Mapp. 2021;42:4658–70.
Seitz J, Cetin-Karayumak S, Lyall A, Pasternak O, Baxi M, Vangel M, et al. Investigating sexual dimorphism of human white matter in a harmonized, multi-site diffusion magnetic resonance imaging study. Cereb Cortex. 2020;31:201–12.
Biase MAD, Zalesky A, Cetin-Karayumak S, Rathi Y, Lv J, Boerrigter D, et al. Large-scale evidence for an association between peripheral inflammation and white matter free water in schizophrenia and healthy individuals. Schizophr Bull. 2020. https://doi.org/10.1093/schbul/sbaa134.
Ye H, Zalesky A, Lv J, Loi SM, Cetin-Karayumak S, Rathi Y, et al. Network analysis of symptom comorbidity in schizophrenia: relationship to illness course and brain white matter microstructure. Schizophr Bull. 2021. https://doi.org/10.1093/schbul/sbab015.
Kelly S, Guimond S, Pasternak O, Lutz O, Lizano P, Cetin-Karayumak S, et al. White matter microstructure across brain-based biotypes for psychosis—findings from the bipolar-schizophrenia network for intermediate phenotypes. Psychiatry Res Neuroimaging. 2021;308:111234.
Di Biase MA, Cetin-Karayumak S, Lyall AE, Zalesky A, Cho KIK, Zhang F, et al. White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis. Mol Psychiatry. 2021;26:6833–44.
Andersson JLR, Sotiropoulos SN. An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging. Neuroimage. 2016;125:1063–78.
Smith SM. Fast robust automated brain extraction. Hum Brain Mapp. 2002;17:143–55.
Ning L, Bonet-Carne E, Grussu F, Sepehrband F, Kaden E, Veraart J, et al. Cross-scanner and cross-protocol multi-shell diffusion MRI data harmonization: algorithms and results. Neuroimage. 2020;221:117128.
Varentsova A, Zhang S, Arfanakis K. Development of a high angular resolution diffusion imaging human brain template. Neuroimage. 2014;91:177–86.
Cetin Karayumak S, Kubicki M, Rathi Y. Harmonizing Diffusion MRI Data Across Magnetic Field Strengths. In: Frangi A, Schnabel J, Davatzikos C, Alberola-López C, Fichtinger G, editors. Medical Image Computing and Computer Assisted Intervention – MICCAI 2018. MICCAI 2018. Lecture Notes in Computer Science, vol. 11072. Springer, Cham; 2018.
Kailath T. The divergence and Bhattacharyya distance measures in signal selection. IEEE Trans Commun Technol. 1967;15:52–60.
Cropley VL, Klauser P, Lenroot RK, Bruggemann J, Sundram S, Bousman C, et al. Accelerated gray and white matter deterioration with age in schizophrenia. Am J Psychiatry. 2017;174:286–95.
Carreira Figueiredo I, Borgan F, Pasternak O, Turkheimer FE, Howes OD. White-matter free-water diffusion MRI in schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology. 2022;47:1413–20.
Fusar‐Poli P, McGorry PD, Kane JM. Improving outcomes of first‐episode psychosis: an overview. World Psychiatry. 2017;16:251–65.
Robinson DG, Schooler NR, Rosenheck RA, Lin H, Sint KJ, Marcy P, et al. Predictors of hospitalization of individuals with first-episode psychosis: data from a 2-year follow-up of the RAISE-ETP. Psychiatr Serv. 2019;70:569–77.
Biase MAD, Katabi G, Piontkewitz Y, Karayumak SC, Weiner I, Pasternak O. Increased extracellular free-water in adult male rats following in utero exposure to maternal immune activation. Brain Behav Immun. 2019. https://doi.org/10.1016/j.bbi.2019.09.010.
Piontkewitz Y, Arad M, Weiner I. Abnormal trajectories of neurodevelopment and behavior following in utero insult in the rat. Biol Psychiatry. 2011;70:842–51.
Gallego JA, Blanco EA, Husain-Krautter S, Fagen EM, Moreno-Merino P, del Ojo-Jiménez JA, et al. Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: new data and an updated meta-analysis. Schizophr Res. 2018. https://doi.org/10.1016/j.schres.2018.07.019.
Coughlin JM, Wang Y, Ambinder EB, Ward RE, Minn I, Vranesic M, et al. In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using |[lsqb]|11C|[rsqb]|DPA-713 PET and analysis of CSF and plasma. Transl Psychiatry. 2016;6:e777.
Söderlund J, Schröder J, Nordin C, Samuelsson M, Walther-Jallow L, Karlsson H, et al. Activation of brain interleukin-1beta in schizophrenia. Mol Psychiatry. 2009;14:1069–71.
Pakkenberg B. Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors. Biol Psychiatry. 1993;34:768–72.
Pakkenberg B. The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics. Schizophr Res. 1992;7:95–100.
Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry. 1990;47:1023–8.
Angoff R, Himali JJ, Maillard P, Aparicio HJ, Vasan RS, Seshadri S, et al. Relations of metabolic health and obesity to brain aging in young to middle‐aged adults. J Am Heart Assoc. 2021;11:e022107.
Andreasen NC, Nopoulos P, Magnotta V, Pierson R, Ziebell S, Ho B-C. Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol Psychiatry. 2011;70:672–9.
Fusar-Poli P, Smieskova R, Kempton MJ, Ho B-C, Andreasen NC, Borgwardt S. Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neurosci Biobehav Rev. 2013;37:1680–91.
Gao X, Zhang W, Yao L, Xiao Y, Liu L, Liu J, et al. Association between structural and functional brain alterations in drug-free patients with schizophrenia: a multimodal meta-analysis. J Psychiatry Neurosci Jpn. 2018;43:131–42.
Tuozzo C, Lyall AE, Pasternak O, James ACD, Crow TJ, Kubicki M. Patients with chronic bipolar disorder exhibit widespread increases in extracellular free water. Bipolar Disord. 2018;20:523–30.
Seitz-Holland J, Nägele FL, Kubicki M, Pasternak O, Cho KIK, Hough M, et al. Shared and distinct white matter abnormalities in adolescent-onset schizophrenia and adolescent-onset psychotic bipolar disorder. Psychol Med. 2022:1–13. https://doi.org/10.1017/S003329172200160X.
Langhein M, Seitz-Holland J, Lyall AE, Pasternak O, Chunga N, Cetin-Karayumak S, et al. Association between peripheral inflammation and free-water imaging in major depressive disorder before and after ketamine treatment—a pilot study. J Affect Disord. 2022;314:78–85.
Maziero MP, Seitz-Holland J, Cho KIK, Goldenberg JE, Tanamatis TW, Diniz JB, et al. Cellular and extracellular white matter abnormalities in obsessive-compulsive disorder: a diffusion magnetic resonance imaging study. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6:983–91.
Garcia TP, Marder K. Statistical approaches to longitudinal data analysis in neurodegenerative diseases: Huntington’s disease as a model. Curr Neurol Neurosci. 2017;17:14.
Aghili M, Tabarestani S, Adjouadi M. Addressing the missing data challenge in multi-modal datasets for the diagnosis of Alzheimer’s disease. J Neurosci Methods. 2022;375:109582.
Rydhög AS, Szczepankiewicz F, Wirestam R, Ahlgren A, Westin C-F, Knutsson L, et al. Separating blood and water: perfusion and free water elimination from diffusion MRI in the human brain. Neuroimage. 2017;156:423–34.
Berger M, Pirpamer L, Hofer E, Ropele S, Duering M, Gesierich B, et al. Free water diffusion MRI and executive function with a speed component in healthy aging. Neuroimage. 2022;257:119303.
Kubicki M, Lyall AE. Antipsychotics and their impact on cerebral white matter: part of the problem or part of the solution? Am J Psychiatry. 2018;175:1056–7.
Karcher NR, Barch DM. The ABCD study: understanding the development of risk for mental and physical health outcomes. Neuropsychopharmacology. 2021;46:131–42.
Elam JS, Glasser MF, Harms MP, Sotiropoulos SN, Andersson JLR, Burgess GC, et al. The Human Connectome Project: a retrospective. Neuroimage. 2021;244:118543.
Seidman LJ, Shapiro DI, Stone WS, Woodberry KA, Ronzio A, Cornblatt BA, et al. Association of neurocognition with transition to psychosis: baseline functioning in the second phase of the North American Prodrome Longitudinal Study. JAMA Psychiatry. 2016;73:1239–1248.
Chung Y, Cannon TD. Brain imaging during the transition from psychosis prodrome to schizophrenia. J Nerv Ment Dis. 2015;203:336–341.
Johnstone EC, Abukmeil SS, Byrne M, Clafferty R, Grant E, Hodges A, et al. Edinburgh high risk study—findings after four years: demographic, attainment and psychopathological issues. Schizophr Res. 2000;46:1–15.
Pantelis C, Velakoulis D, Wood SJ, Yücel M, Yung AR, Phillips LJ, et al. Neuroimaging and emerging psychotic disorders: the Melbourne ultra-high risk studies. Int Rev Psychiatry. 2007;19:371–81.
Addington J, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, et al. North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophr Res. 2012;142:77–82.
Yung AR, Nelson B. Young people at ultra high risk for psychosis: research from the PACE clinic. Rev Bras Psiquiatr. 2011;33:s143–60.